Source: BMJ Open Diabetes Research & Care. Unidade: FCFRP
Subjects: DIABETES MELLITUS, CUSTOS DE MEDICAMENTOS, CUSTOS DOS CUIDADOS DE SAÚDE, FARMACOTERAPIA
ABNT
GONÇALVES, Ana Carolina Oliveira et al. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care, v. 7, p. e000647, 2019Tradução . . Disponível em: https://doi.org/10.1136/bmjdrc-2018-000647. Acesso em: 14 nov. 2024.APA
Gonçalves, A. C. O., Cazarim, M. de S., Sanches, C., Pereira, L. R. L., Camargos, A. M. T., Aquino, J. A., & Baldoni, A. O. (2019). Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus. BMJ Open Diabetes Research & Care, 7, e000647. doi:10.1136/bmjdrc-2018-000647NLM
Gonçalves ACO, Cazarim M de S, Sanches C, Pereira LRL, Camargos AMT, Aquino JA, Baldoni AO. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus [Internet]. BMJ Open Diabetes Research & Care. 2019 ; 7 e000647.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1136/bmjdrc-2018-000647Vancouver
Gonçalves ACO, Cazarim M de S, Sanches C, Pereira LRL, Camargos AMT, Aquino JA, Baldoni AO. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus [Internet]. BMJ Open Diabetes Research & Care. 2019 ; 7 e000647.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1136/bmjdrc-2018-000647